TickerFacts.

Sera Prognostics, Inc. (SERA): EPS (Basic)

Annual figures by period end, from SEC filings.

-$0.67
Year ended 2025-12-31
2020-12-31: -$12.762021-12-31: -$2.332022-12-31: -$1.432023-12-31: -$1.162024-12-31: -$0.992025-12-31: -$0.67-$0.67
2020-12-31 EPS (Basic) (USD per share) 2025-12-31
Period endedEPS (Basic)Change YoYSource filing
2025-12-31-$0.67n/m2026-03-18, From 2025-01-01
2024-12-31-$0.99n/m2026-03-18, From 2024-01-01
2023-12-31-$1.16n/m2025-03-19, From 2023-01-01
2022-12-31-$1.43n/m2024-03-20, From 2022-01-01
2021-12-31-$2.33n/m2023-03-22, From 2021-01-01
2020-12-31-$12.76n/a2022-03-29, From 2020-01-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Basic)Change YoY
Sera Prognostics, Inc. (SERA)2025-12-31-$0.67n/m
Aclarion, Inc. (ACON)2025-12-31-$13.61n/m
YD Bio Ltd (YDES)2025-12-31-$0.12n/m
American Shared Hospital Services (AMS)2025-12-31-$0.23n/m
Exagen Inc. (XGN)2025-12-31-$0.93n/m
Personalis, Inc. (PSNL)2025-12-31-$0.91n/m
Biodesix Inc (BDSX)2025-12-31-$4.67n/m
GRAIL, Inc. (GRAL)2025-12-31-$11.11n/m
BillionToOne, Inc. (BLLN)2025-12-31$0.18n/m

Compare SERA, ACON, YDES, AMS side by side · Screen every company in Services-Medical Laboratories ↗